Iadonato S P, Bu G, Maksymovitch E A, Schwartz A L
Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Biochem J. 1993 Dec 15;296 ( Pt 3)(Pt 3):867-75. doi: 10.1042/bj2960867.
We have recently described a PAI-1-independent pathway of tissue-type plasminogen activator (t-PA) uptake and degradation on the rat MH1C1 hepatoma cell line. Further studies have implicated the low-density-lipoprotein-receptor-related protein (LRP) as the mediator of plasminogen-activator inhibitor type-1-independent t-PA endocytosis. The LRP is a multi-functional receptor which is shared by a variety of ligands, including alpha 2-macroglobulin, apoprotein E-enriched beta-very-low-density lipoprotein, t-PA and Pseudomonas exotoxin A. In each case, binding of ligand to this receptor can be inhibited by addition of the 39 kDa LRP-receptor-associated protein. This protein, which co-purifies with the LRP receptor, is the focus of our present study. 125I-labelled 39 kDa protein binds specifically and with high affinity to a single kinetic binding species on the rat MH1C1 cell surface. Scatchard analysis reveals an equilibrium dissociation constant (Kd) of 3.3 +/- 0.9 (S.D.) nM, with 380,000 +/- 190,000 (S.D.) binding sites per cell. Cross-linking studies indicate that the specific interaction between MH1C1 cells and the 39 kDa protein is mediated by an association with the LRP receptor. The 39 kDa protein strongly inhibits binding of 125I-t-PA, with an apparent Ki value of 0.5 nM. In addition, both unlabelled t-PA and 125I-labelled 39 kDa protein can be co-bound and cross-linked to the same cell-associated LRP receptor. Endocytosis of cell-surface-associated 39 kDa protein was shown to be rapid, with internalized ligand subsequently degraded and released to the extracellular milieu. The rate of uptake and degradation of 125I-labelled 39 kDa protein at 37 degrees C was determined to be 52 fmol/min per 10(6) cells, and supports a model for active recycling of the LRP receptor.
我们最近描述了大鼠MH1C1肝癌细胞系上组织型纤溶酶原激活剂(t-PA)摄取和降解的一条不依赖纤溶酶原激活剂抑制物-1(PAI-1)的途径。进一步的研究表明,低密度脂蛋白受体相关蛋白(LRP)是纤溶酶原激活剂抑制物-1非依赖性t-PA内吞作用的介质。LRP是一种多功能受体,多种配体均可与之结合,包括α2-巨球蛋白、富含载脂蛋白E的β-极低密度脂蛋白、t-PA和铜绿假单胞菌外毒素A。在每种情况下,添加39 kDa的LRP受体相关蛋白均可抑制配体与该受体的结合。这种与LRP受体共同纯化的蛋白是我们目前研究的重点。125I标记的39 kDa蛋白特异性且高亲和力地结合到大鼠MH1C1细胞表面的单一动力学结合位点。Scatchard分析显示平衡解离常数(Kd)为3.3±0.9(标准差)nM,每个细胞有380,000±190,000(标准差)个结合位点。交联研究表明,MH1C1细胞与39 kDa蛋白之间的特异性相互作用是由与LRP受体的结合介导的。39 kDa蛋白强烈抑制125I-t-PA的结合,表观Ki值为0.5 nM。此外,未标记的t-PA和125I标记的39 kDa蛋白均可共同结合并交联到同一细胞相关的LRP受体上。细胞表面相关的39 kDa蛋白的内吞作用迅速,内化的配体随后被降解并释放到细胞外环境中。在37℃下,125I标记的39 kDa蛋白的摄取和降解速率被测定为每10(6)个细胞52 fmol/min,并支持LRP受体的主动循环模型。